Parametric Portfolio Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $21.4M | Buy |
227,836
+44,616
| +24% | +$3.78M | 0.01% | 914 |
|
|
2021
Q4 | $15.6M | Sell |
183,220
-42,894
| -19% | -$3.95M | 0.01% | 1099 |
|
|
2021
Q3 | $21.7M | Buy |
226,114
+3,698
| +2% | +$349K | 0.01% | 886 |
|
|
2021
Q2 | $21.6M | Buy |
222,416
+40,878
| +23% | +$3.92M | 0.01% | 918 |
|
|
2021
Q1 | $17.7M | Buy |
181,538
+20,148
| +12% | +$2.11M | 0.01% | 1238 |
|
|
2020
Q4 | $15.5M | Sell |
161,390
-23,962
| -13% | -$2.31M | 0.01% | 1246 |
|
|
2020
Q3 | $17.8M | Buy |
185,352
+6,689
| +4% | +$774K | 0.01% | 970 |
|
|
2020
Q2 | $21.8M | Buy |
178,663
+6,753
| +4% | +$746K | 0.02% | 828 |
|
|
2020
Q1 | $14.9M | Buy |
171,910
+4,881
| +3% | +$478K | 0.01% | 970 |
|
|
2019
Q4 | $18M | Buy |
167,029
+44,577
| +36% | +$4.67M | 0.01% | 1057 |
|
|
2019
Q3 | $11M | Buy |
122,452
+15,234
| +14% | +$1.42M | 0.01% | 1384 |
|
|
2019
Q2 | $9.05M | Buy |
107,218
+15,698
| +17% | +$1.29M | 0.01% | 1548 |
|
|
2019
Q1 | $8.06M | Buy |
91,520
+3,173
| +4% | +$265K | 0.01% | 1585 |
|
|
2018
Q4 | $6.31M | Sell |
88,347
-23,288
| -21% | -$2.23M | 0.01% | 1697 |
|
|
2018
Q3 | $13.7M | Buy |
111,635
+18,595
| +20% | +$2.11M | 0.01% | 1191 |
|
|
2018
Q2 | $9.14M | Buy |
93,040
+11,283
| +14% | +$1.01M | 0.01% | 1443 |
|
|
2018
Q1 | $6.78M | Buy |
81,757
+7,227
| +10% | +$610K | 0.01% | 1645 |
|
|
2017
Q4 | $5.78M | Buy |
74,530
+14,290
| +24% | +$975K | 0.01% | 1788 |
|
|
2017
Q3 | $3.69M | Buy |
60,240
+13,422
| +29% | +$708K | ﹤0.01% | 2114 |
|
|
2017
Q2 | $2.15M | Sell |
46,818
-6,241
| -12% | -$303K | ﹤0.01% | 2482 |
|
|
2017
Q1 | $2.3M | Buy |
53,059
+4,212
| +9% | +$180K | ﹤0.01% | 2355 |
|
|
2016
Q4 | $1.89M | Sell |
48,847
-8,983
| -16% | -$407K | ﹤0.01% | 2401 |
|
|
2016
Q3 | $2.93M | Sell |
57,830
-12,796
| -18% | -$637K | ﹤0.01% | 2053 |
|
|
2016
Q2 | $3.21M | Buy |
70,626
+22,781
| +48% | +$1.05M | 0.01% | 1943 |
|
|
2016
Q1 | $1.89M | Buy |
47,845
+24,558
| +105% | +$975K | ﹤0.01% | 2447 |
|
|
2015
Q4 | $1.32M | Sell |
23,287
-3,751
| -14% | -$191K | ﹤0.01% | 2573 |
|
|
2015
Q3 | $1.08M | Buy |
27,038
+2,786
| +11% | +$135K | ﹤0.01% | 2274 |
|
|
2015
Q2 | $1.16M | Buy |
24,252
+2,692
| +12% | +$114K | ﹤0.01% | 2693 |
|
|
2015
Q1 | $856K | Buy |
21,560
+4,589
| +27% | +$164K | ﹤0.01% | 2903 |
|
|
2014
Q4 | $379K | Sell |
16,971
-604
| -3% | -$11.4K | ﹤0.01% | 3423 |
|
|
2014
Q3 | $275K | Buy |
17,575
+1,185
| +7% | +$17.7K | ﹤0.01% | 3497 |
|
|
2014
Q2 | $243K | Sell |
16,390
-578
| -3% | -$8.16K | ﹤0.01% | 3634 |
|
|
2014
Q1 | $273K | Buy |
16,968
+1,000
| +6% | +$17.1K | ﹤0.01% | 3484 |
|
|
2013
Q4 | $149K | Sell |
15,968
-45
| -0.3% | -$439 | ﹤0.01% | 3680 |
|
|
2013
Q3 | $181K | Sell |
16,013
-668
| -4% | -$9.18K | ﹤0.01% | 3626 |
|
|
2013
Q2 | $223K | Buy |
+16,681
| New | +$205K | ﹤0.01% | 3424 |
|
Other funds holding NBIX
BG
DM
